Amed Co., Ltd. (7575.TWO)

TWD 41.65

(-2.0%)

Market Cap (In TWD)

1.24 Billion

Revenue (In TWD)

763.82 Million

Net Income (In TWD)

91.71 Million

Avg. Volume

25.05 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
39.85-71.3
PE
-
EPS
-
Beta Value
0.0
ISIN
TW0007575B17
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
-
Employee Count
-
Website
https://www.amed.com.tw
Ipo Date
2022-06-28
Details
Amed Co., Ltd. engages in the research and development, manufacture, and trading of medical equipment in Taiwan. It offers wound care dressing products under the HERADERM brand name; negative pressure wound therapy systems that provides 24-hour oxygen supply to wounds under the Genadyne brand name; and wound treatment systems under the Natrox brand name. The company also provides 7-day long-acting pain reliever injections under the Naldebain brand name. In addition, it offers pressure injectable implantable port kits under the POLYSITE brand; and universal linear cutting staplers under the easyEndo brand name. The company was founded in 2008 and is based in New Taipei City, Taiwan.